Wealth Management Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
JEST
Wealth Management Associates's GSK Position: Q1 2026 in Review
Wealth Management Associates increased its GSK (GSK) stake by 0.12% in Q1 2026, buying an estimated $271 and bringing the position to 4,129 shares worth $228K. The position accounts for 0.08% of the portfolio, ranked #213.
Wealth Management Associates first reported a position in GSK in Q4 2018 and has held it in 17 quarters since. The position peaked at $337K in Q4 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Wealth Management Associates held 4,129 shares of GSK worth $228K as of Q1 2026.
- Wealth Management Associates bought 5 GSK shares in Q1 2026, an estimated $271.
- GSK made up 0.08% of Wealth Management Associates's portfolio in Q1 2026, its #213 holding.
- Wealth Management Associates first reported a position in GSK in Q4 2018 and has held it in 17 quarters since.
- Wealth Management Associates's GSK position peaked at $337K in Q4 2019.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Wealth Management Associates's 13F filing for Q1 2026, filed 13 May 2026.